BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang HJ, Guo Z, Yang YT, Jiang JH, Qi YP, Li JJ, Li LQ, Xiang BD. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis. World J Gastroenterol 2016; 22(21): 5088-5095 [PMID: 27275101 DOI: 10.3748/wjg.v22.i21.5088]
URL: https://www.wjgnet.com/1948-5182/full/v22/i21/5088.htm
Number Citing Articles
1
Zhenhao Chen, Guanglei Zhao, Feiyan Chen, Jun Xia, Li Jiang. The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremitiesBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5511-x
2
Weibin Wang, Fang Wang, Qingqing Chen, Shuyi Ouyang, Yutaro Iwamoto, Xianhua Han, Lanfen Lin, Hongjie Hu, Ruofeng Tong, Yen-Wei Chen. Phase Attention Model for Prediction of Early Recurrence of Hepatocellular Carcinoma With Multi-Phase CT Images and Clinical DataFrontiers in Radiology 2022; 2 doi: 10.3389/fradi.2022.856460
3
Ayman Bannaga, Ramesh P Arasaradnam. Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic reviewWorld Journal of Gastroenterology 2020; 26(33): 5022-5049 doi: 10.3748/wjg.v26.i33.5022
4
SooYoon Sung, Seok Hyun Son, Eun Young Park, Chul Seung Kay, Giancarlo Troncone. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapyPLOS ONE 2017; 12(3): e0173955 doi: 10.1371/journal.pone.0173955
5
Youya Zang, Peiyun Long, Ming Wang, Shan Huang, Chuang Chen. Development and validation of prognostic nomograms in patients with hepatocellular carcinoma: a population-based studyFuture Oncology 2021; 17(36): 5053 doi: 10.2217/fon-2020-1065
6
Mohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio. Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review articleAnnals of Hepatology 2021; 22: 100249 doi: 10.1016/j.aohep.2020.08.067
7
Jie Lin, Binbin Xue, Jia Li, Huaqing Xu, Xiaming Huang, Zhichao Yao, Xiang Li, Junhui Xia. Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSDNeurological Sciences 2017; 38(10): 1859 doi: 10.1007/s10072-017-3068-5
8
Yunjiao Wang, Chuchu Peng, Zhigang Cheng, Ximei Wang, Lei Wu, Jingyi Li, Changsheng Huang, Qulian Guo, Hongwei Cai. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysisInternational Journal of Surgery 2018; 55: 73 doi: 10.1016/j.ijsu.2018.05.022
9
Xiaowei Qiu, Haiqing Zhang, Dongxu Li, Jing Wang, Zhigang Jiang, Yuanzhong Zhou, Ping Xu, Jun Zhang, Zhanhui Feng, Changyin Yu, Zucai Xu. Analysis of Clinical Characteristics and Poor Prognostic Predictors in Patients With an Initial Diagnosis of Autoimmune EncephalitisFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01286
10
Hao-Jie Yang, Jing-Hang Jiang, Yu-Ting Yang, Xiang-Di Yang, Zhe Guo, Ya-Peng Qi, Feng-Hua Zeng, Ke-Lan Zhang, Neng-Zhi Chen, Bang-De Xiang, Le-Qun Li. Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survivalWorld Journal of Gastroenterology 2016; 22(39): 8798-8805 doi: 10.3748/wjg.v22.i39.8798
11
João Paulo Maciel Silva, Fabricio Ferreira Coelho, Alex Jones Flores Cassenote, Vagner Birk Jeismann, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, José Donizeti de Meira Júnior, Sérgio Carlos Nahas, Paulo Herman. Preoperative inflammatory markers as prognostic predictors after hepatocellular carcinoma resection: data from a western referral centerBMC Surgery 2022; 22(1) doi: 10.1186/s12893-022-01779-6
12
Yu-Ting Yang, Jing-Hang Jiang, Hao-Jie Yang, Zhi-jun Wu, Ze-Min Xiao, Bang-De Xiang. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resectionScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20199-2
13
Hao-Jie Yang, Jing-Hang Jiang, Qing-An Liu, Cheng-Mao Zhou, Yang-feng Du, Tao Wu, Neng-Zhi Chen, Bang-De Xiang. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resectionTumor Biology 2017; 39(6): 101042831770737 doi: 10.1177/1010428317707375
14
Sheng-chao Li, Zhuo Xu, Yan-li Deng, Ya-ni Wang, Yu-ming Jia. Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinomaMedicine 2020; 99(27): e20919 doi: 10.1097/MD.0000000000020919
15
Weibin WANG, Qingqing CHEN, Yutaro IWAMOTO, Xianhua HAN, Qiaowei ZHANG, Hongjie HU, Lanfen LIN, Yen-Wei CHEN. Deep Learning-Based Radiomics Models for Early Recurrence Prediction of Hepatocellular Carcinoma with Multi-phase CT Images and Clinical Data2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2019; : 4881 doi: 10.1109/EMBC.2019.8856356
16
Qian Zhu, Qiu-Zhong Pan, Ai-Lin Zhong, Hao Hu, Jing-Jing Zhao, Yan Tang, Wan-Ming Hu, Min Li, De-Sheng Weng, Ming-Yuan Chen, Gang Ma, Jian-Chuan Xia. Annexin A3 upregulates the infiltrated neutrophil-lymphocyte ratio to remodel the immune microenvironment in hepatocellular carcinomaInternational Immunopharmacology 2020; 89: 107139 doi: 10.1016/j.intimp.2020.107139
17
Sang Yun Ha, Sangjoon Choi, Sujin Park, Jong Man Kim, Gyu-Seong Choi, Jae-Won Joh, Cheol-Keun Park. Prognostic effect of preoperative neutrophil-lymphocyte ratio is related with tumor necrosis and tumor-infiltrating lymphocytes in hepatocellular carcinomaVirchows Archiv 2020; 477(6): 807 doi: 10.1007/s00428-020-02841-5
18
Guang-Tao Min, Yu-Min Li, Nan Yao, Jun Wang, Hong-Peng Wang, Wei Chen. The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysisClinical Transplantation 2018; 32(1): e13151 doi: 10.1111/ctr.13151
19
Yan Liao, Rongyu Wei, Renzhi Yao, Liling Qin, Jun Li, Junxiong Yu, Weijia Liao. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective studyBMC Surgery 2021; 21(1) doi: 10.1186/s12893-020-01037-7
20
Wei Zhang, Chang Liu, Yifei Tan, Li Jiang, Lunan Yan, Jiayin Yang, Tianfu Wen. Role of liver resection in treating intermediate and advanced stage adolescent and young adult hepatocellular carcinoma patients: A propensity-matching cohort studyInternational Journal of Surgery 2018; 54: 259 doi: 10.1016/j.ijsu.2018.03.051
21
Hao-Jie Yang, Jing-Hang Jiang, Yu-Ting Yang, Zhe Guo, Ji-jia Li, Xuan-han Liu, Fei Lu, Feng-Hua Zeng, Jin-Song Ye, Ke-Lan Zhang, Neng-Zhi Chen, Bang-De Xiang, Le-Qun Li. Stratified aspartate aminotransferase-to-platelet ratio index accurately predicts survival in hepatocellular carcinoma patients undergoing curative liver resectionTumor Biology 2017; 39(3): 101042831769594 doi: 10.1177/1010428317695944
22
So Jeong Yoon, Hongbeom Kim, Okjoo Lee, Ji Hye Jung, Chang-Sup Lim, Yong Chan Shin, Wooil Kwon, Jin-Young Jang, Sang Hyun Shin, Jin Seok Heo, In Woong Han. Development and external validation of a nomogram with inflammatory markers for predicting invasiveness of intraductal papillary mucinous neoplasm of pancreasMedicine 2022; 101(11) doi: 10.1097/MD.0000000000029036
23
Linda Wong, Kliment Bozhilov, Brenda Hernandez, Sandi Kwee, Owen Chan, Luke Ellis, Loic LeMarchand. Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratioClinical and Molecular Hepatology 2019; 25(3): 305 doi: 10.3350/cmh.2019.0004
24
Weibin Wang, Qingqing Chen, Yutaro Iwamoto, Panyanat Aonpong, Lanfen Lin, Hongjie Hu, Qiaowei Zhang, Yen-Wei Chen. Deep Fusion Models of Multi-Phase CT and Selected Clinical Data for Preoperative Prediction of Early Recurrence in Hepatocellular CarcinomaIEEE Access 2020; 8: 139212 doi: 10.1109/ACCESS.2020.3011145
25
Mitsuru Yanagaki, Koichiro Haruki, Jungo Yasuda, Kenei Furukawa, Shinji Onda, Masashi Tsunematsu, Yoshihiro Shirai, Takeshi Gocho, Tomohiko Taniai, Ryoga Hamura, Toru Ikegami. The Significance of the Rapid Turnover Protein Score as a Predictor of the Long-Term Outcomes in Hepatocellular Carcinoma After Hepatic ResectionAnnals of Surgical Oncology 2021; 28(13): 8130 doi: 10.1245/s10434-021-10704-9
26
Lingling He, Shuan Zhang, Xiaoli Liu, Yuyong Jiang, Xianbo Wang, Zhiyun Yang. HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes MellitusJournal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/3819502
27
Mitsuru Yanagaki, Yoshihiro Shirai, Ryoga Hamura, Tomohiko Taniai, Yoshiaki Tanji, Koichiro Haruki, Kenei Furukawa, Shinji Onda, Hiroaki Shiba, Toru Ikegami. Novel combined fibrosis-based index predicts the long-term outcomes of hepatocellular carcinoma after hepatic resectionInternational Journal of Clinical Oncology 2022; 27(4): 717 doi: 10.1007/s10147-021-02111-7
28
Wei Zhang, Yifei Tan, Shu Shen, Li Jiang, Lunan Yan, Jiayin Yang, Bo Li, Tianfu Wen, Yong Zeng, Wen Tao Wang, Mingqing Xu. Prognostic nomogram for hepatocellular carcinoma in adolescent and young adult patients after hepatectomyOncotarget 2017; 8(63): 106393 doi: 10.18632/oncotarget.18192
29
Xueqin Shen, Wei Wang, Xiaoping Niu. Neutrophil Lymphocyte Ratio to Albumin Ratio and White Blood Cell to Hemoglobin Ratio as Prognostic Markers for Hepatocellular Carcinoma Patients Who Underwent Curative HepatectomyInternational Journal of General Medicine 2021; : 5029 doi: 10.2147/IJGM.S329911
30
Jia-Xi Mao, Fei Teng, Cong Liu, Hang Yuan, Jia-Yong Dong, Hong Fu, Guo-Shan Ding, Wen-Yuan Guo. Immunometabolic inflammation and hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2019; 18(3): 298 doi: 10.1016/j.hbpd.2019.03.012